Stem cell transplantation for non-malignant disorders
- 1 September 2000
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 13 (3) , 343-363
- https://doi.org/10.1053/beha.2000.0082
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- BONE MARROW TRANSPLANTATION FOR BETA-THALASSEMIAHematology/Oncology Clinics of North America, 1999
- Influence of CD34 cell selection on the incidence of mixed chimaerism and minimal residual disease after allogeneic unrelated donor transplantationLeukemia, 1998
- Hurler Syndrome: II. Outcome of HLA-Genotypically Identical Sibling and HLA-Haploidentical Related Donor Bone Marrow Transplantation in Fifty-Four ChildrenBlood, 1998
- Same-day determination of chimaeric status in the immediate period following allogeneic bone marrow transplantation.British Journal of Haematology, 1997
- Phlebotomy to Reduce Iron Overload in Patients Cured of Thalassemia by Bone Marrow TransplantationBlood, 1997
- Persistence of fetal hemoglobin production after successful transplantation of cord blood stem cells in a patient with sickle cell anemiaThe Journal of Pediatrics, 1996
- Bone marrow transplantation in a young child with sickle cell anemiaAmerican Journal of Hematology, 1995
- The toxicity of busulphan and cyclophosphamide as the preparative regimen for bone marrow transplantationBritish Journal of Haematology, 1991
- MARROW TRANSPLANTATION FOR THALASSAEMIAThe Lancet, 1982
- IMMUNOLOGICAL RECONSTITUTION OF SEX-LINKED LYMPHOPENIC IMMUNOLOGICAL DEFICIENCYThe Lancet, 1968